Halozyme Therapeutics, Inc. (HALO)
71.32
-0.21
(-0.29%)
USD |
NASDAQ |
Jun 08, 14:33
Halozyme Therapeutics Market Cap : 8.453B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 112.66B |
| Agenus, Inc. | 121.34M |
| Altimmune, Inc. | 354.20M |
| Lineage Cell Therapeutics, Inc. | 301.65M |
| Amgen, Inc. | 186.05B |
Market Cap Related Metrics
| PE Ratio | 25.65 |
| PS Ratio | 5.757 |
| Price to Book Value | 38.49 |
| Price to Free Cash Flow | 13.01 |
| Price | 71.32 |
| Earnings Yield | 3.90% |
| Operating PE Ratio | 10.11 |
| Normalized PE Ratio | 14.62 |